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Autism spectrum conditions (henceforth autism) are lifelong, neurodevelopmental conditions 
characterized by social and communication difficulties; markedly restricted, repetitive interests 
and behaviour; and differences in cognitive profile, including atypical sensory perception and 
information processing, motor abilities, and intellectual ability (APA, 2013). Although historically 
autism was classified as a rare condition, prevalence estimates have increased in recent years 
and now approximately 1-2% of the population are diagnosed as autistic (likely due to expansion 
of diagnostic criteria and greater recognition of the condition due to increased awareness) (Baio 
et al., 2018). In addition, there is a sex-bias in autism, with males being diagnosed approximately 
three to four times more frequently than females (Baio et al., 2018; Loomes, Hull, and Mandy, 
2017). Due to historic increases in prevalence, greater numbers of autistic individuals continue 
to reach adolescence and adulthood.  
 
Autistic individuals are at higher risk of premature mortality than non-autistic individuals, with 
some evidence of further increased risks for those with intellectual disability and for autistic 
females; in addition, chronic physical health conditions or poor physical health are associated 
with premature mortality for autistic individuals across the spectrum of intellectual ability 
(Bishop-Fitzpatrick et al., 2018; DaWalt et al., 2019; Hirvikoski et al., 2016; Hwang et al., 2019; 
Woolfenden et al., 2012). Despite these risks, there are very few studies of autistic adults with a 




To date, eight large-scale studies have attempted to identify the common medical comorbidities 
of autistic adults in a variety of ways. However, almost none of these studies effectively consider 
physical health across the lifespan: three studies only include autistic individuals younger than 
40 years of age, and an additional three include less than 325 autistic people aged 40+ years each. 
Despite these limitations, all of these six studies indicate that autistic individuals are at increased 
risk of nearly every physical health condition asked about; taken collectively, this includes 
increased risk of neurological conditions and CNS anomalies (and in particular epilepsy/ seizure 
disorders), cardiovascular conditions (including dyslipidemia/ lipid metabolism disorders, 
hypertension, and stroke), gastrointestinal conditions, metabolic conditions and diabetes 
(including Type I diabetes, being overweight, and obesity), pulmonary/ respiratory conditions 
(including asthma and COPD), immune/ autoimmune conditions, endocrine conditions (including 
thyroid conditions), pubertal disorders, genitourinary/ kidney conditions, musculoskeletal 
conditions, sleep disturbances/ disorders, nutritional conditions, muscular dystrophy, genetic 
disorders, physical disabilities, skin disorders, infections, hematological disorders, jaw and teeth 
disorders, ENT (ear, nose, and throat) conditions, and ophthalmological conditions for young 
autistic individuals compared to young non-autistic individuals (Croen et al., 2015; Davignon et 
al., 2018; Fortuna et al., 2016; Kohane et al., 2012; Vohra, Madhavan, and Sambamoorthi, 2017; 
Weiss et al., 2018).  
 
It should be noted that some of these studies reported that autistic individuals were at relatively 
lower risk for some conditions compared to non-autistic individuals, including migraines, 
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musculoskeletal conditions, genitourinary conditions, cancer, cardiovascular disorders, diabetes, 
and respiratory conditions (Croen et al., 2015; Davignon et al., 2018; Fortuna et al., 2016; Vohra, 
Madhavan, and Sambamoorthi, 2017); however, there are conflicting results across different 
studies for each of these conditions. For example, there is genetic and epidemiological evidence 
to suggest that autistic individuals have a different likelihood of developing cancer than those in 
the general population, yet due to methodological differences across studies (primarily regarding 
limited sample sizes and age range), the direction of this risk is still under debate (Chiang et. al, 
2015; Crawley, Heyer, and LaSalle, 2016; Crespi, 2011; Darbro et al., 2016; Kao et al., 2010; 
Mouridsen et al., 2016; Vohra, Madhavan, and Sambamoorthi, 2017; Wen, Alshikho, and 
Herbert, 2016).  Even taking these limitations into account, there appears to be a pattern of 
increased health burden for most physical health conditions among autistic individuals.  
 
Further, three studies (including two of the above) of primarily younger autistic adults considered 
healthcare utilization (in regards to number of visits or expense), showing that autistic individuals 
are more likely than non-autistic individuals to have outpatient, inpatient, primary care, 
emergency room, mental health/ psychiatric, neurology, speech therapy, and laboratory visits; 
have prescription drug claims; and to be hospitalized (Vohra, Madhavan, and Sambamoorthi, 
2017; Weiss et al., 2018; Zerbo et al., 2018). Thus, it is unsurprising that they also had higher 
mean annual expenditure for outpatient, primary care, emergency, mental health/ psychiatry, 
neurology, home health care, and skilled nursing visits; prescription drug claims; and overall 
healthcare than non-autistic individuals (and the presence of a psychiatric or physical health 
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comorbidity increased expenditure further) (Vohra, Madhavan, and Sambamoorthi, 2017; Weiss 
et al., 2018; Zerbo et al., 2018). 
 
In addition to the six studies of primarily younger adults, two recent studies attempt to quantify 
increased physical health comorbidity burden for autistic adults across the lifespan. The first 
utilized census records in the Scottish population (n = 6,649 autistic adults) and identified 
increased risks for autistic adults over the age of 25 compared to non-autistic adults in all the 
categories surveyed, with odds ratios (ORs) of 6.2 and 2.6 for physical disability and other 
conditions (which may include physical health conditions), respectively (Rydzewska et al., 2018). 
Unfortunately, the census data did not provide any information about physical health specifically, 
or about any particular physical health conditions.  
 
The second utilized a large, cross-sectional sample of Medicare data (n= 4,685 autistic adults) to 
determine whether older autistic adults (specifically those 65 years of age or older) are at 
increased risk of physical and mental health conditions (Hand et al., 2020). They found that, 
compared to individuals in the general population, autistic adults were at increased risk of nearly 
every condition tested (except menopausal disorders, multiple sclerosis, back conditions, and 
substance use disorders, whose findings were non-significant); for physical health specifically, 
the study confirmed previous findings from studies of younger adults (increased risk of all other 
metabolic, neurological, respiratory, gastrointestinal, circulatory/ cardiovascular, and 
musculoskeletal conditions) and identified that older autistic adults were also at increased risk of 
cancer, heart disease, and cerebrovascular disease (Hand et al., 2020). The findings of this study 
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highlight the need for research in autistic adults across the lifespan (and particularly in older 
adults), as they may have greater and/ or different risks than younger autistic individuals.  
 
Finally, in addition to increased risk of specific health conditions, some studies indicate that there 
may be risk factors that have knock-on effects for autistic adults, placing them at even higher 
likelihood of developing a variety of physical health conditions than those in the general 
population. First, all of the studies that investigated potential sex differences in healthcare 
burden found that autistic females had even greater risks for most physical health conditions and 
lower reported health status overall than autistic males (Croen et al., 2015; Davignon et al., 2018; 
Fortuna et al., 2016; Rydzewska et al., 2018); these findings are in line with mortality data which 
shows that autistic females are at uniquely increased risk of premature mortality even compared 
to autistic males (Hirvikoski et al., 2016; Hwang et al., 2019; Woolfenden et al., 2012). Based on 
these findings, new research should focus on identifying physical health risks in autistic males 
and females separately, as well as quantifying relative risk between these groups.  Second, two 
recent studies show evidence of cardiovascular risk factors that may contribute to greater risk of 
a variety of conditions among autistic individuals compared to non-autistic individuals, including 
reduced cardiorespiratory capacity and reduced heart-rate variability (Bricout et al., 2018; Thapa 
et al., 2019). Third, a systematic review and meta-analysis confirm the findings of Croen et al. and 
Hand et al. to suggest that autistic individuals are at greater risk of obesity than non-autistic 
people (Croen et al., 2015; Hand et al., 2020; Zheng et al., 2017). Obesity has been shown to be 
significantly associated with increased risk of several non-communicable diseases, including type 
II diabetes, cancer, cardiovascular conditions overall, and asthma (Guh et al., 2009). Fourth, there 
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is still significant debate regarding frequency of substance use and abuse in autism, and how this 
may affect physical health of autistic adults. Several small studies indicate decreased substance 
use among autistic individuals overall (Croen et al., 2015; Davignon et al., 2018; Fortuna et al., 
2016; Vohra, Madhavan, and Sambamoorthi, 2017). Conversely, other studies have suggested 
increased substance use problems among autistic adults, including a large population-based 
study in Sweden (n = 26,986 autistic individuals) which suggests that autism is a risk factor for 
substance use-related problems, with elevated risks even for relatives of autistic individuals 
(Butwicka et al., 2016; Weiss et al., 2018). Substance use/ abuse increases risks of respiratory 
problems (including asthma), cancer, heart disease, hypertension, heart attack, stroke, 
reproductive morbidity, diabetes, liver damage/disease, and sleep conditions (Schulte and Hser, 
2014). We are unaware of any large-scale studies of physical health comorbidity burden of 
autistic adults that take into account lifestyle factors like obesity, smoking, or alcohol use. Thus, 
it appears that autistic adults, and particularly autistic females, may experience higher rates of 
nearly all types of physical health conditions, which may affect both quality and length of life. 
 
Considering the significantly increased risks of premature mortality among autistic adults, it is of 
particular import to identify which physical health conditions are contributing the most risk. In 
2016, the WHO reported that 71% of worldwide mortality was accounted for by four non-
communicable diseases: cancers, cardiovascular conditions, respiratory conditions, and diabetes; 
therefore, research on physical health of autistic adults should focus on identifying differences in 
these key areas to maximize potential public health impact. In order to create effective 
interventions to reduce risk of physical health conditions and premature mortality, new research 
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must aim to identify risks for cancers, cardiovascular conditions, respiratory conditions, and 
diabetes  across the lifespan, quantify risks for autistic females specifically, and determine 









We developed an anonymous, online physical health survey that included questions about 
demographic information, a short version of the Autism Spectrum Quotient (a measure of autistic 
traits, AQ-10) (Allison et al 2012; Greenberg et al, 2018), daily habits (including exercise, diet, 
sleep, disability, and social/ sexual history), as well as personal and family medical histories of 
common medical conditions. The medical history sections included lists of conditions from the 
broad categories of cancer; cardiovascular; respiratory; gastrointestinal; hormonal/reproductive; 
musculoskeletal; neurological; eye; ear, nose, and throat; liver and kidney; blood and lymph; skin; 
diabetes; and autoimmune conditions.  
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The questionnaire comprised 512 questions, asking about more than 150 medical conditions and 
daily habits. To avoid survey fatigue, the medical history sections utilized a tiered structure. 
Participants were directed to first select the broad health category that corresponded to each of 
their health conditions and, based on their selections, additional questions appeared with lists of 
common conditions within the selected category. In addition, each category list included a free 
text box where participants could report a diagnosis of any condition about which the survey did 
not specifically inquire. Further, there was a final text box at the end of the medical history 
section asking if there was any additional information that participants wished to provide about 
their health or medical history. As the survey used a tiered design, we scanned all free text boxes 
to ensure that conditions listed throughout the personal medical history section were 
appropriately coded, and that conditions listed met our requirements for inclusion. Medical 
conditions were ascertained by asking “Which of the following conditions have you ever had? 
Please select all that apply:” for each of the selected categories, indicating that individuals should 
provide a cumulative medical history across their lifespan rather than over a specified time limit 
(e.g. the last five years). See Supplementary Information for additional details. The conditions 
were selected using online, publicly available materials from the National Health Service (NHS), 
Cancer Research United Kingdom (CRUK), National Institute for Health and Care Excellence 
(NICE), National Institutes of Health (NIH), and the World Health Organization (WHO).  
 
Recruitment 
This study utilized a convenience sampling framework, recruiting online participants via the 
Cambridge Autism Research Database (CARD), Autistica’s Discover Network, autism support 
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groups and charities (including the Autism Research Trust), and social media (specifically Twitter 
and Facebook). These sampling methods may be biased toward those with autism or an interest 
in autism, as we advertised to groups/ forums related to autism; however, all advertisements 
encouraged participation from both autistic and non-autistic individuals. In addition, we used 
Facebook to advertise our study to the general population, in an attempt to limit bias from 
recruiting individuals via only autism-specific groups/ forums; in this phase of recruitment, both 
autistic and non-autistic Facebook users from around the world were invited to participate. The 
study aimed to include an international cohort of individuals from all countries, and respondents 
from over 60 different countries were included in the sample.  
 
Survey collection took place between February 2018 to August 2019. There were two periods 
within this time where survey collection was paused; no changes were made to the survey during 
these periods. We performed a sensitivity analysis covarying for time period in Model 2 and used 
z-tests to determine if the pauses in survey collection affected our results; we found no 
statistically significant differences in the results.  
 
The Cohort 
N = 3,657 individuals accessed the survey. Participants included any individual who was at least 
16 years of age and consented to participate. We excluded 1,102 individuals due to ‘incomplete’ 
response, meaning that they exited the survey before providing their medical history. 914 of the 
individuals excluded due to incomplete response (83%) did not even complete the demographics 
section of the survey (and answered no questions related to lifestyle or physical health), making 
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their responses unusable for this analysis. Some questions were optional, and individuals were 
not excluded from analysis if they chose to skip optional questions; however, all questions related 
to medical history were required. We excluded one individual that indicated ‘Other’ for their 
biological sex, as our analysis strategy splits participants by biological sex.  
 
As the survey was anonymous, we used an algorithm to exclude potential duplicate responses (n 
= 108). We excluded all records that matched a previous record on 11 criteria (autism diagnosis 
(yes/no), specific autism diagnosis, type of diagnosing practitioner, year of autism diagnosis, 
country of residence, biological sex, current gender identity, education-level, age, maternal age 
at birth, and paternal age at birth).  
 
 We used a case-control design to divide our sample into an autistic cohort and a control cohort. 
Our autistic cohort included individuals with an autism diagnosis, provided by a medical 
practitioner. Autism diagnoses were self-reported; however, we asked participants to provide 
additional information to verify their diagnosis, such as the type of practitioner who diagnosed 
them (e.g. Psychiatrist, Clinical Psychologist, Pediatrician, etc), year of their diagnosis, specific 
diagnosis (Autism Spectrum Disorder, Asperger’s, etc), and whether they have a syndromic form 
of autism. As we followed a case-control design, individuals who self-diagnosed as autistic, 
suspected autism, or were waiting to be assessed for autism were excluded from both the autistic 
and non-autistic (control) groups (n = 44). We also excluded those who reported a syndromic 
form of autism (n = 34) that carries known physical health risks (i.e. Klinefelter/XXY, PTEN 
Hamartoma Tumor Syndrome, etc.,). Our control population included any individuals who do not 
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have autism or suspect autism; as noted above, individuals who report a self-diagnosis of autism, 
suspected autism, or who are waiting to be assessed with autism were excluded from the control 
group in order to preserve the case-control design. There were no additional exclusion criteria 




As noted above, approximately 71% of worldwide mortality can be attributed to four non-
communicable diseases: cancers, cardiovascular conditions, respiratory conditions, and diabetes. 
Considering the increased risks of premature mortality to autistic individuals, we limited our 
analyses to these four broad categories of physical health and tested risks overall, as well as by 
condition for all conditions reported with at least 1% prevalence in the cohort being tested. By 
restricting our analyses to these conditions that account for such a large proportion of worldwide 
mortality, we were able to employ more in-depth analyses on the differences in prevalence 
between autistic and non-autistic adults, as well as consider effects of lifestyle factors (smoking, 
alcohol, BMI), age, and sex. As such, we designed this analysis with the hopes of identifying 
specific points of intervention for healthcare providers, autistic individuals, and caregivers which, 
in turn, might serve to reduce risks of chronic disease and premature mortality among autistic 
individuals.     
 
We used R Version 3.6.2 to employ three sex-stratified statistical models, comparing rates of 
medical conditions among autistic females vs. non-autistic females, and separately, autistic males 
 13 
vs. non-autistic males. We chose to segregate all our analyses by biological sex, as mortality and 
prevalence of physical health conditions in the general population vary greatly by biological sex 
(Oksuzyan et al., 2008; Verbrugge, Wingard, and Hayworth Continuing Features Submission, 
1987), and some studies suggest that autistic females may be at even higher risk of health 
conditions and premature mortality (Croen et  al., 2015; Davignon et al., 2018; Hirvikoski et al., 
2016; Hwang et al., 2019; Rydzewska et al., 2018; Woolfenden et al., 2012).  
 
The first model used sex-stratified one-tailed Fisher’s exact tests. The second utilized sex-
stratified binomial logistic regression (specifically Firth’s Bias-Reduced Logistic Regression using 
the R package ‘logistf’) and controlled for demographic factors, including age, ethnicity, country 
of residence, and educational level (as a crude measure of socioeconomic status). The third also 
utilized sex-stratified binomial logistic regression and controlled for the same demographic 
factors, as well as some factors that may be related to lifestyle choices and daily habits, including 
Body Mass Index (BMI), alcohol use, and smoking. We used frequency of current alcohol 
consumption, as measured by the number of days per week with the following options: “I do not 
consume alcoholic beverages”, “1-2 days per week”, “3-4 days per week”, and “5-7 days per 
week”, to quantify alcohol use among participants. We used highest frequency of smoking ever, 
as measured by the regularity of smoking when smoking most frequently with the following 
options: “I have never smoked regularly”, “Monthly”, “Weekly”, and “Daily”, to quantify smoking 
among participants. We employed multiple imputation (using predictive mean matching within 
the MICE package) to address missingness in the data for the variables of age, BMI, educational-
level, ethnicity, country of residence, smoking, and alcohol (Azur et al., 2011). We used 
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imputation exclusively for the covariates, therefore, the imputation only affected Model 2 and 
Model 3. We employed the False Discovery Rate correction to minimize the risks of Type I errors 
from multiple testing in both models and used a p-threshold of 0.05 for all three models 
(Benjamini & Hochberg, 1995). We also conducted z-tests to compare the relative risk of 
conditions between females and males, in order to determine whether our study replicates 
previous findings to suggest relatively larger risk of physical health conditions among autistic 
females in our sample, compared to autistic males. Finally, we performed post-hoc analyses on 
Model 2 to investigate the interaction of age and diagnosis on the likelihood of developing each 
of our outcomes of interest. 
 
Ethical Approval 
This study received ethical approval (HBREC.2017.28) from the University of Cambridge Human 





The mean age of the autistic group was 40.98 years of age (sd = 14.41) and the mean age of the 
control group was 41.84 years (sd = 15.50). The groups did not differ in age (Chi^2 = 81.878, df = 
67, p > 0.05). Our sample was biased toward females, white individuals, and UK residents, and 
there were significant group differences. This was expected based on the methodology and 
recruitment strategies employed. Table 1 includes a summary of demographic information for 
both the autistic and non-autistic participants. 
 
Table 1: Participant Demographics 
Characteristics 
Autism  
(n = 1,156) 
Controls  
(n = 1,212) 
p-values  
(Signif. Level) 
Age (years), mean (SD) 40.98 (14.41) 41.84 (15.50) 0.304  
Age (years), categories, N (%)    
16-29 298 (25.78) 311 (25.66)  
30-39 246 (21.28) 245 (20.21)  
40-49 243 (21.02) 256 (21.12)  
50-59 212 (18.34) 210 (17.33)  
60-69 108 (9.34) 124 (10.23)  
70+ 25 (2.16) 52 (4.29)  
Missing 24 (2.08) 14 (1.16)  
Biological Sex, N (%)   0.017 ( * ) 
Female 738 (63.84) 830 (68.48)  
Male 418 (36.16) 382 (31.52)  
Missing 0 0  
Ethnicity, N (%)   5.074 x 10-7 ( *** ) 
White 1021 (88.32) 1029 (84.90)  
Mixed Race 74 (6.40) 75 (6.19)  
Asian 18 (1.56) 41 (3.38)  
Latin American/ Hispanic 7 (0.61) 23 (1.90)  
Arab/ Middle Eastern 0 (0.00) 17 (1.40)  
Jewish 16 (1.38) 17 (1.40)   
African/ Black/ Caribbean 6 (0.52) 9 (0.74)  
Missing 14 (1.21) 1 (0.08)  
Education, N (%)   1.609 x 10-16 ( *** ) 
No formal qualifications 53 (4.58) 13 (1.07)  
Further vocational qualifications 206 (17.82) 140 (11.55)  
Secondary School/ High School 208 (17.99) 171 (14.11)  
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University Undergraduate 348 (30.10) 358 (29.54)  
University Postgraduate 339 (29.33) 527 (43.48)  
Missing 2 (0.17) 3 (0.25)  
Country of Residence   3.126 x 10-7 ( *** ) 
United Kingdom 821 (71.02) 765 (63.12)  
United States of America 118 (10.21) 175 (14.44)  
Germany 30 (2.60) 33 (2.72)  
Australia 32 (2.77) 21 (1.73)  
Canada 25 (2.16) 24 (1.98)  
Ireland 13 (1.12) 30 (2.48)  
Netherlands 28 (2.42) 8 (0.66)  
Other 89 (7.70) 156 (12.87)  
Missing 1 (0.09) 3 (0.25)  
Body Mass Index (kg), mean (SD) 27.74 (8.30) 26.60 (6.87) 3.999 x 10-3 ( *** ) 
     Missing 25 (2.16) 20 (1.65)  
Most Frequent Smoking, N (%)   0.031 ( * ) 
     Never 783 (67.73) 779 (64.27)  
     Monthly 2 (0.17) 9 (0.74)  
     Weekly 25 (2.16) 41 (3.38)  
     Daily 346 (29.93) 382 (31.52)  
     Missing 0 1 (0.08)  
Current Alcohol Frequency, N (%)   2.344 x 10-20 ( *** ) 
     0 days per week 675 (58.39) 469 (38.70)  
     1-2 days per week 292 (25.26) 475 (39.19)  
     3-5 days per week 119 (10.29) 183 (15.10)  
     6-7 days per week 69 (5.97) 84 (6.93)  
     Missing 1 (0.09) 1 (0.08)  
SD = standard deviation 
p-values were from Pearson’s Chi Square test (categorical) or from a Mann-Whitney U test (means) 
Note: These are demographic data before imputation. The results remain highly similar after imputation. 
 
 
The following figures illustrate the reported prevalence of non-communicable diseases among 
autistic and non-autistic adults. Figure 1 shows the prevalence of the four large categories of non-
communicable diseases that cumulatively account for the majority of worldwide mortality each 
year, as reported by the WHO. Figure 2 clarifies the prevalence of the specific conditions with at 
least 1% prevalence among the cohort being tested.   
 
 
<INSERT FIGURES 1 and 2 HERE> 
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Summary of Results from all Three Models 
Using one-tailed Fisher’s exact tests, Model 1 provided us with an unadjusted model and is, 
thereby, the least conservative in estimating group differences between autistic and non-autistic 
adults. Model 1 found that autistic females are at increased risk of cardiovascular conditions 
overall and respiratory conditions overall, as well as specifically for low blood pressure, 
arrhythmias, asthma, and prediabetes than non-autistic females. Autistic males have elevated 
risks of cardiovascular conditions overall, as well as high cholesterol, arrhythmias, and Type II 
Diabetes, compared to non-autistic males. Supplementary Table 1 provides the complete results 
for Model 1.  
 
Model 2 employed binomial logistic regression and controlled for demographic factors to reduce 
bias from our sampling methods (age, ethnicity, country of residence, and education-level) and 
attempts to quantify the group differences, regardless of which factors account for these 
differences. Model 2 found that autistic females have higher rates of cardiovascular, respiratory, 
and diabetic conditions overall, as well as specifically for low blood pressure, arrhythmias, 
asthma, and prediabetes than non-autistic females. Compared to non-autistic males, autistic 
males are at increased risk of arrhythmias. Supplementary Table 2 provides the complete results 
for Model 2.  
 
Finally, Model 3 also used binomial logistic regression and controlled for the same demographic 
factors, and also controlled for factors that could be related to lifestyle and daily habits, including 
BMI, alcohol use, and smoking. Thus, Model 3 attempts to quantify risks between autistic and 
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non-autistic females and males, respectively, that expands beyond particular lifestyle choices, 
such as BMI, smoking, and alcohol use. Model 3 found that autistic females are more likely than 
non-autistic females to have cardiovascular, respiratory, and diabetic conditions overall, as well 
as specifically for low blood pressure, arrhythmias, asthma, and prediabetes; in addition, it found 
higher risk of arrhythmias for autistic males than for non-autistic males. Supplementary Table 3 
provides the complete results for Model 3. Table 2 shows the results of the three models together 
































Table 2: Summary of All Three Sex-Stratified Models 
Conditions 
Model 1 Model 2 Model 3 Signif. 
Models OR 95% CI Sig. OR 95% CI Sig. OR 95% CI Sig. 
Cancer           
 Female 0.830 0.517, Inf  1.098 0.627, 1.911  1.068 0.605, 1.872   
 Male 0.864 0.484, Inf  0.840 0.431, 1.628  0.739 0.367, 1.473   
Cardiovascular            
 Female 1.306 1.039, Inf * 1.511 1.139, 2.010 ** 1.383 1.033, 1.854 * 1, 2, 3 
 Male 1.438 1.082, Inf * 1.590 1.104, 2.302  1.542 1.056, 2.262  1 
Respiratory           
 Female 1.898 1.511, Inf *** 2.016 1.541, 2.647 *** 2.054 1.557, 2.719 *** 1, 2, 3 
 Male 1.067 0.745, Inf  0.955 0.623, 1.464  0.903 0.583, 1.399   
Diabetic           
 Female 1.450 1.034, Inf  1.835 1.223, 2.771 ** 1.692 1.109, 2.599 * 2, 3 
 Male 1.668 1.015, Inf  1.731 0.979, 3.132  1.509 0.822, 2.830   
Low Blood Pressure           
 Female 2.941 1.842, Inf *** 2.900 1.716, 5.073 *** 2.541 1.494, 4.467 ** 1, 2, 3 
High Blood Pressure           
 Female 0.755 0.549, Inf  0.965 0.650, 1.426  0.873 0.578, 1.313   
 Male 1.185 0.838, Inf  1.292 0.850, 1.975  1.158 0.743, 1.812   
High Cholesterol           
 Female 0.980 0.666, Inf  1.435 0.892, 2.313  1.382 0.850, 2.248   
 Male 1.679 1.110, Inf * 1.523 0.924, 2.542  1.451 0.867, 2.456  1 
Heart Disease           
 Male 1.307 0.652, Inf  1.146 0.520, 2.593  1.121 0.501, 2.562   
Arrhythmia           
 Female 2.871 1.913, Inf *** 2.941 1.854, 4.783 *** 2.928 1.829, 4.804 *** 1, 2, 3 
 Male 2.917 1.644, Inf ** 2.979 1.556, 6.047 * 3.085 1.561, 6.458 * 1, 2, 3 
Asthma           
 Female 1.978 1.565, Inf *** 2.069 1.571, 2.736 *** 2.092 1.576, 2.789 *** 1, 2, 3 
 Male 0.925 0.631, Inf  0.832 0.527, 1.313  0.796 0.499, 1.267   
Type II Diabetes           
 Female 0.805 0.455, Inf  1.237 0.637, 2.386  1.028 0.510, 2.055   
 Male 3.388 1.374, Inf * 2.483 0.995, 7.150  1.799 0.688, 5.266  1 
Prediabetes           
 Female 3.153 1.687, Inf ** 4.337 2.147, 9.395 *** 4.379 2.102, 9.772 *** 1, 2, 3 
 Male 0.767 0.353, Inf  1.075 0.461, 2.483  1.020 0.419, 2.474   
Significance Level:    *** (p < 0.001),          ** (p < 0.01),          * (p < 0.05),           (p < 0.10) 
OR = Odds Ratio 
95% CI = 95% Confidence Interval 
Sig.  = Significance Level 
Sig. Models = Significant Models 
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In addition, we performed an interaction analysis, again using binomial logistic regression to 
determine if there was a significant interaction between age and autism diagnosis. There were 
marginally significant interactions between age and diagnosis for cardiovascular conditions 
overall for autistic females (compared to non-autistic females), as well as for high cholesterol and 
heart disease for autistic males (compared to non-autistic males); however, these results did not 
survive correction.  Full results for this analysis are provided in Supplementary Table 4. 
 
Finally, we performed z-tests on Models 2 and 3 to determine if there was relatively increased 
risk for any of the physical health conditions tested, based on biological sex. Our results support 
that autistic females are significantly more likely than autistic males to have respiratory 
conditions overall, as well as asthma and prediabetes specifically. There were no significant 
differences between autistic males and females for any other condition tested; full results are 

















Table 3: Risks of Conditions for Autistic Females vs. Autistic Males 
Conditions 

















Cancer 1.098 0.840 0.876  1.068 0.739 0.655  
Cardiovascular  1.511 1.590 0.966  1.383 1.542 0.900  
Respiratory 2.016 0.955 0.018 * 2.054 0.903 8.754 x 10-3 ** 
Diabetic 1.835 1.731 0.966  1.692 1.509 0.900  
High Blood Pressure 0.965 1.292 0.630  0.873 1.158 0.655  
High Cholesterol 1.435 1.523 0.966  1.382 1.451 0.900  
Arrhythmia 2.941 2.979 0.975  2.928 3.085 0.900  
Asthma 2.069 0.832 7.500 x 10-3 ** 2.092 0.796 4.481 x 10-3 ** 
Type II Diabetes 1.237 2.483 0.497  1.028 1.799 0.655  
Prediabetes 4.337 1.075 0.027 * 4.379 1.020 0.024 * 
Significance Level:    *** (p < 0.001),          ** (p < 0.01),          * (p < 0.05),           (p < 0.10) 
Note: We could not test sex differences for Low Blood Pressure or Heart Disease, as these were only tested in one 
sex each (females and males, respectively) for the purposes of this study 













By utilizing three statistical models, we were able to parse out risks to a population of autistic 
adults more specifically than in previous studies. Results that demonstrate differences in physical 
health comorbidity across all three models suggests that these differences exist, regardless of 
both demographic and lifestyle-related factors. We found that, compared to non-autistic 
females, autistic females are more likely to have a cardiovascular condition (OR: 1.51), 
approximately twice as likely to have a respiratory condition (OR: 2.02) and asthma specifically 
(OR: 2.07), nearly 3 times as likely to have low blood pressure (OR: 2.90) and arrhythmias (OR: 
2.94), and over 4 times as likely to have prediabetes (OR: 4.34); and that autistic males are also 
nearly three times as likely to have arrhythmias (OR: 2.98) than non-autistic males. It seems that 
both autistic females and males carry these increased risks, even when accounting for age, 
ethnicity, education-level, country of residence, BMI, smoking, and alcohol use. Therefore, this 
suggests that autistic adults have these increased health risks, even after taking into account the 
potential risks associated with obesity and substance use problems (which may be higher in 
autistic individuals) (Butwicka et al., 2016; Croen et al., 2015; Weiss et al., 2018; Zheng et al., 
2017). 
 
There is also limited evidence of elevated risks of diabetic conditions (OR: 1.84) for autistic 
females, as well as greater risks of cardiovascular conditions (OR: 1.59), high cholesterol (OR: 
1.52), and Type II diabetes (OR: 2.48) for autistic males. However, these results are only 
supported by one or two models, so need to be taken as preliminary evidence at this stage.  
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In sum, the present results confirm previous findings of increased risks for diabetes (including 
prediabetes and Type II diabetes), cardiovascular conditions (including high cholesterol), and 
asthma (Croen et. al, 2015; Davignon et al., 2018; Weiss et al., 2018). Our findings do not confirm 
the results reported by Vohra and colleagues, which found decreased risk of cardiovascular, 
respiratory, and diabetic conditions; however, our participants may display greater physical 
health burden due to our sample’s wider age range, as the earlier study only included 255 autistic 
participants over the age of 40 years (Vohra, Madhavan, and Sambamoorthi, 2017). Finally, our 
results extend previously reported conditions for autistic adults to include elevated risk of low 
blood pressure for autistic females, as well as increased risk of arrhythmias for both autistic 
females and autistic males. 
 
We also tested the effects of age on developing these physical health conditions. Within our 
sample, we found no significant interaction between autism diagnosis and age. These results 
could reflect true patterns, suggesting that increasing age may similarly affect risk of developing 
chronic physical health conditions among both autistic and non-autistic individuals; alternatively, 
our sample could be underpowered to detect the interaction between autism diagnosis and age. 
Another important point to note is that we ask participants to report whether they have ever had 
a condition and do not ask the age at which the condition was diagnosed. As such, our study may 
not have the sensitivity in detecting effects of age. This may be particularly true for conditions, 
such as asthma, which are frequently diagnosed during childhood; thus, our results reflect the 
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cumulative likelihood of developing these conditions across the lifespan of each individual, rather 
than the conditions diagnosed exclusively during adulthood or over a particular time frame. 
 
In regard to sex differences, our results suggest that autistic females may have excess risk of 
developing respiratory conditions, asthma, and prediabetes compared to autistic males. We 
found no significant differences in any other conditions tested which again may reflect true 
differences, or we may be underpowered due to undersampling of males. Increased risks among 
autistic females reported in our study align with previous findings from both mortality data 
(Hirvikoski et al., 2016; Woolfenden et al., 2012) and physical health studies (Croen et al., 2015; 
Davignon et al., 2018; Rydzewska et al., 2018), but expand the specific list of conditions for which 
autistic females may have excess risk. Further, these findings may have important policy 
implications for healthcare providers of autistic females: this group may require additional 





Whilst both autistic males and females appear to have increased physical health risks, this study 
is under-powered to provide reliable effect size differences between autistic and non-autistic 
adults, and particularly for rare medical conditions. Due to its relatively small sample size for 
epidemiological research, it may be subject to the ‘winner’s curse’, resulting in artificially inflated 
odds ratios. Instead, it provides evidence of relatively increased risk for autistic adults across the 
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lifespan, which should be investigated further. In addition, future research should attempt to 
recruit larger samples, in order to consider differences in risk of physical health comorbidity 
across age groups, by comparing prevalence of health conditions among young, middle-aged, and 
older adults separately. 
 
This study used a self-report survey measure, rather than medical records. Thus, our study relied 
on participants to provide an accurate account of their physical health conditions, which may 
introduce bias into our sample. The study may also be subject to sampling bias, as we advertised 
the study via various sources of social media, and autism support groups and charities. Further, 
the survey was only available in English, and this may have biased our sample as well.  
 
Another limitation is that our methodology excluded participants who are unable to participate 
in an online, self-report survey. This likely limited our analyses to individuals with access to the 
internet, as well as average intellectual ability and physical functioning, which is not 
representative of the entire autistic population. Evidence from mortality data (Hirvikoski et al., 
2016; Hwang et al., 2019; Woolfenden et al., 2012) suggests that autistic individuals with 
intellectual disability may be at particularly high risk for premature mortality and that the specific 
risk factors for premature mortality in this group may be different to autistic individuals without 
intellectual disability. Future research should focus on identifying the physical health risks of 
autistic individuals across the spectrum of intellectual ability and physical functioning.  
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Our control population may not be representative of the general population, as our recruiting 
methods may have been more likely to reach individuals with an interest in autism, or who may 
suspect that they are autistic. We excluded individuals from both the autistic and control groups 
who reported self-diagnosis of autism or suspected they are autistic. However, even with these 
exclusions, we cannot preclude the possibility that our control group may include some 
individuals with undiagnosed autism, high autistic traits, a broad autistic phenotype, or genetic 
liability for autism. Thus, our results may underestimate true group differences between autistic 
and non-autistic individuals.   
 
It was particularly challenging to recruit males (both autistic and non-autistic) to the sample; this 
was expected, as self-report surveys are typically heavily biased toward female respondents, and 
this pattern is reported specifically for online surveys focused on healthcare (Aerny-Perreten et 
al., 2015; Cheung et al., 2017; Cull et al., 2005; Listyowardojo et al., 2011). We expect that under-
sampling of males limited our power and, thereby, our sensitivity in identifying smaller 
differences in physical health risks between autistic and non-autistic males. However, our results 
support that autistic females and males both have increased risks compared to the non-autistic 




Although previous studies have found increased health risks for autistic individuals, the current 
research expands the breadth of conditions that are associated with autistic adults. Self-report 
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survey measures tend to attract female respondents disproportionately (Aerny-Perreten et al., 
2015; Cheung et al., 2017; Cull et al., 2005; Listyowardojo et al., 2011), allowing us to sample a 
large group of autistic females. Existing studies of autistic adults use medical, insurance, or census 
records to determine physical health comorbidities. Thus, their data will include a strong sex bias 
toward males within their autism population (approximately 3:1 or 4:1). As such, the existing 
study of physical health of autistic adults fails to consider unique risks of autistic females, due to 
under-sampling of this population; however, prevalence of physical health conditions varies 
greatly by biological sex in the general population (Oksuzyan et al., 2008; Verbrugge, Wingard, 
and Hayworth Continuing Features Submission, 1987). Our methodology also allowed us to 
recruit a large, international cohort and, thereby, to reach a greater number of autistic adults 
across the lifespan, and especially understudied groups: 738 autistic females, an average age of 
approximately 41 years in both the autistic and control groups, and 588 autistic participants aged 
40 years or older. As the largest sample of middle-aged and older autistic females, our results 
make clear that there are significant health risks to this group, even when taking lifestyle factors 
into account.  
 
Another advantage of our methodology is that our study had very little missing data; missing data 
and the biases introduced by imputation are significant issues in retrospective medical record 
analysis. Model 1 in our study avoided any biases from imputation; and while some values for 
the seven covariates were imputed in Model 2 and Model 3, 2.16% or less of the data for any 
variable were missing for either the autistic or non-autistic groups. 
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A final strength of our methodology is that we are the first large-scale study to quantify the effect 
of lifestyle factors (such as smoking, alcohol use, and BMI) on risk of developing chronic physical 
health conditions among autistic adults. Specifically, our analyses focus on identifying differences 
in prevalence of cancers, cardiovascular conditions, respiratory conditions, and diabetic 
conditions, and their relationship to lifestyle factors; collectively these conditions account for 
over 70% of worldwide mortality, and our study provides insight into some of the increased 
physical health risks that may contribute to premature mortality seen among autistic individuals 
across the spectrum. As our results suggest that these physical health risks remain even after 
accounting for differences in lifestyle factors, this study may have implications for future 
healthcare of autistic adults, and the importance of healthcare maintenance checks in preventing 
premature mortality among autistic individuals. 
 
Contributing Factors 
There are several reasons that autistic adults may carry a greater physical health burden than 
others. As autism is polygenic in nature, there may be overlapping genetic risks from either rare 
or common variants between autism and physical health conditions. A recent study utilized 
pathway network analyses to show that genes associated with autism may also provide 
vulnerability to chronic medical conditions, including cancer, cardiovascular conditions, and 
metabolic conditions (and specifically Type II diabetes) (Wen, Alshikho, and Herbert, 2016). We 
excluded individuals who reported genetic syndromes that are known to have clear physical 
health risks; however, future research should focus on utilizing both genetic and health data 
together, in order to establish relative genetic risk of particular conditions. Another biological 
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factor that may affect risk of developing physical health conditions is dysregulation of sex steroid 
hormones; autistic individuals may be more likely to have elevated prenatal steroidogenic 
activity, later hormone dysregulation, and/or hormone-related health conditions in later 
adulthood (Baron-Cohen et al., 2015; Baron-Cohen & Tsompanidis et al., 2019; Berni et al., 2018; 
Cherskov et al., 2018; Kosidou et al., 2016; Pohl et al., 2014; Ruta et al., 2011; Schwarz et al., 
2011), which may in turn increase likelihood of developing obesity and a variety of physical health 
conditions including cancer, diabetes, cardiovascular conditions (Berni et al., 2018; Bhupathy, 
Haines, & Leinwand, 2010; Brand et al., 2011; Cherskov et al., 2018; Kosidou et al., 2016; 
Mantovani & Fucic, 2014).  
 
Further, while our study attempts to control for some lifestyle factors, these measures are limited 
in their ability to detail actual lifestyle differences between autistic and non-autistic adults. Our 
sample only accounts for participants’ currently alcohol consumption frequency and the 
frequency of their smoking when smoking the most; additionally, we know that body mass index 
may correspond to lifestyle choices, including diet and exercise, but also may relate to genetic or 
other unknown factors as well. Future research should focus on establishing lifestyle differences 
between middle-aged and older autistic and non-autistic adults that could contribute to physical 
health risks.  
 
Recent research has identified that autistic adults may be at higher risk of negative life 
experiences (Griffiths et al., 2019) and that, in children, these negative life experiences can affect 
their health (Rigles 2016). Finally, differences in the prevalence of physical health conditions may 
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be related to the quality of care received by autistic individuals. There is evidence of increased 
healthcare utilization among autistic adults, with one study even suggesting that autistic adults 
may carry double the total annual mean healthcare costs of individuals in the general population 
(Vohra, Madhavan, and Sambamoorthi, 2017; Weiss et al., 2018; Zerbo et al., 2019). Despite this, 
autistic adults report lower satisfaction with patient-provider communication, lower self-efficacy 
for both general healthcare and chronic conditions, higher odds of unmet healthcare needs 
related to physical health, and greater odds of using emergency care (Nicolaidis et al., 2013). 
Further, a recent systematic review found that patient-provider communication, sensory 
sensitivities, and executive functioning/ planning issues served as significant barriers to accessing 
healthcare for autistic individuals; in addition, negative experiences with healthcare providers 
and healthcare providers’ lack of knowledge of autism both served as barriers in at least one of 
the studies included (Mason et al., 2019). Lack of appropriate healthcare services and of useful 
support may magnify underlying healthcare risks by failing to provide early intervention.  
 
In order to reduce the risk of physical health comorbidities in autistic adults, future research must 
focus on establishing the relative contribution of each of these factors to the physical health risks 






This study reports evidence of increased physical health risks for autistic adults in the areas of 
cardiovascular, respiratory, and diabetic conditions. Many of these risks remain for autistic 
individuals, even when taking alcohol use, smoking, and BMI into account. The 2016 WHO report 
states that these conditions account for a large proportion of premature mortality in the general 
population. We know that autistic individuals are at elevated risk of premature mortality. 
Therefore, future research should focus on further clarifying physical health risks to autistic 
adults across the lifespan that may contribute to premature mortality, as well as establishing the 
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Supplementary Material  
 
We have provided images of the questionnaire to display how the relevant physical health survey 
questions appeared to participants, including the categories or specific non-communicable 
conditions for which this paper provided results. As the study employed a tiered structure design, 
participants were first directed to the question shown in Figure 1 below, and were asked to 
identify the relevant categories for their personal medical history: 
 
Figure 1: List of Condition Categories 
<INSERT SUPPLEMENTARY MATERIAL, FIGURE 1 HERE> 
Follow-up questions would only appear for participants that selected particular category. We 
provided different questions for types of cancer females and males, based on participants’ 
selection for their gender assigned at birth, as certain cancers are sex-specific (such as ovarian or 
testicular cancer) and others are far more common in one sex (such as breast cancer). The cancer 
questions are shown in Figures 2 and 3.  
 
 
Figure 2: List of Cancer Types for Females 
 




Figure 3: List of Cancer Types for Males 
 
<INSERT SUPPLEMENTARY MATERIAL, FIGURE 3 HERE> 
 
Participants were also able to select two broad categories that related to cardiovascular 
conditions, Heart Condition or Risk of Stroke. Both of these conditions led to the same list of 
conditions related to cardiovascular health; this follow-up question is shown in Figure 4.  
 
 
Figure 4: List of Cardiovascular Conditions 
 
<INSERT SUPPLEMENTARY MATERIAL, FIGURE 4 HERE> 
Participants that selected the category for Lung Condition were directed to the following set of 




Figure 5: List of Respiratory Conditions 
 
<INSERT SUPPLEMENTARY MATERIAL, FIGURE 5 HERE> 
Participants that selected the category for Prediabetes or Diabetes were directed to the following 
set of conditions, shown in Figure 6.  
 
 
Figure 6: List of Diabetic Conditions 
 
<INSERT SUPPLEMENTARY MATERIAL, FIGURE 6 HERE> 
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Finally, participants were directed to a final free-text question, in case they had missed out on a 
condition or wanted to provide information relating to their health or medical history that was 
not covered by the preceding questions of the survey. This question is show in Figure 7. 
 
 
Figure 7: Free-text Question on Health or Medical History 
 
<INSERT SUPPLEMENTARY MATERIAL, FIGURE 7 HERE> 
As our study utilized the tiered structure design, data cleaning involved searching all free text 
boxes of each record to ensure that all conditions were coded correctly. We performed this data 
cleaning in order to correct for any errors introduced by the tiered structure design of the survey.  
 
We corrected coding as necessary, to ensure that any condition listed throughout the survey 
(including the questions relating to syndromes, disabilities, autoimmune conditions, and the final 
free-text question) was coded in the appropriate category. In addition, we corrected coding in 
order to meet our criteria for non-communicable diseases. For example, individuals who selected 
the broad category of ‘Lung Condition’ but only listed a particular infection and no other 
respiratory conditions, such as pneumonia or whooping cough (which are communicable 
diseases), were re-coded to note that they did not possess a respiratory condition. While the vast 
majority of respondents coded all conditions correctly, we wanted to ensure that conditions 
listed anywhere by participants were associated with the correct category. 
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Cancer (Overall)      
 Female 0.830 0.517—Inf 0.799 0.882  
 Male 0.864 0.484—Inf 0.732 0.801  
Cardiovascular (Overall)      
 Female 1.306 1.039—Inf 0.027 0.049 * 
 Male 1.438 1.082—Inf 0.017 0.049 * 
Respiratory (Overall)      
 Female 1.898 1.511—Inf 8.821 x 10-7 4.851 x 10-6 *** 
 Male 1.067 0.745—Inf 0.417 0.573  
Diabetic (Overall)      
 Female 1.450 1.034—Inf 0.035 0.054 A A 
 Male 1.668 1.015—Inf 0.045 0.098 A A 
Low Blood Pressure      
 Female 2.941 1.842—Inf 2.135 x 10-5 5.872 x 10-5 *** 
High Blood Pressure      
 Female 0.755 0.549—Inf 0.949 0.949  
 Male 1.185 0.838—Inf 0.226 0.414  
High Cholesterol      
 Female 0.980 0.666—Inf 0.579 0.796  
 Male 1.679 1.110—Inf 0.018 0.049 * 
Heart Disease      
 Male 1.307 0.652—Inf 0.306 0.481  
Arrhythmia      
 Female 2.871 1.913—Inf 2.091 x 10-6 7.667 x 10-6 *** 
 Male 2.917 1.644—Inf 4.492 x 10-4 4.942 x 10-3 ** 
Asthma      
 Female 1.978 1.565—Inf 3.473 x 10-7 3.821 x 10-6 *** 
 Male 0.925 0.631—Inf 0.680 0.801  
Type II Diabetes      
 Female 0.805 0.455—Inf 0.802 0.882  
 Male 3.388 1.374—Inf 8.764 x 10-3 0.048 * 
Prediabetes      
 Female 3.153 1.687—Inf 5.405 x 10-4 1.189 x 10-3 ** 
 Male 0.767 0.353—Inf 0.801 0.801  
Significance Level:    *** (p < 0.001),          ** (p < 0.01),          * (p < 0.05),           (p < 0.10) 
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Supplementary Table 2: Model 2, Sex-Stratified Health Risks by Condition  
















Cancer (Overall)      
 Female 1.098 0.627—1.911 0.741 0.815  
 Male 0.840 0.431—1.628 0.603 0.830  
Cardiovascular (Overall)      
 Female 1.511 1.139—2.010 4.192 x 10-3 6.587 x 10-3 ** 
 Male 1.590 1.104—2.302 0.013 0.069 A A 
Respiratory (Overall)      
 Female 2.016 1.541—2.647 2.636 x 10-7 1.450 x 10-6 *** 
 Male 0.955 0.623—1.464 0.832 0.866  
Diabetic (Overall)      
 Female 1.835 1.223—2.771 3.285 x 10-3 6.022 x 10-3 A**A 
 Male 1.731 0.979—3.132 0.059 0.163  
Low Blood Pressure      
 Female 2.900 1.716—5.073 5.046 x 10-5 1.110 x 10-4 *** 
High Blood Pressure      
 Female 0.965 0.650—1.426 0.857 0.857  
 Male 1.292 0.850—1.975 0.230 0.423  
High Cholesterol      
 Female 1.435 0.892—2.313 0.136 0.188  
 Male 1.523 0.924—2.542 0.099 0.218  
Heart Disease      
 Male 1.146 0.520—2.593 0.736 0.866  
Arrhythmia      
 Female 2.941 1.854—4.783 2.855 x 10-6 1.047 x 10-5 *** 
 Male 2.979 1.556—6.047 7.885 x 10-4 8.674 x 10-3 * 
Asthma      
 Female 2.069 1.571—2.736 1.850 x 10-7 1.450 x 10-6 *** 
 Male 0.832 0.527—1.313 0.430 0.676  
Type II Diabetes      
 Female 1.237 0.637—2.386 0.526 0.643  
 Male 2.483 0.995—7.150 0.051 0.163  
Prediabetes      
 Female 4.337 2.147—9.395 2.523 x 10-5 6.937 x 10-5 *** 
 Male 1.075 0.461—2.483 0.866 0.866  
Significance Level:    *** (p < 0.001),          ** (p < 0.01),          * (p < 0.05),           (p < 0.10) 
 46 
Supplementary Table 3: Model 3, Sex-Stratified Health Risks by Condition  
















Cancer (Overall)      
 Female 1.068 0.605—1.872 0.820 0.902  
 Male 0.739 0.367—1.473 0.390 0.612  
Cardiovascular (Overall)      
 Female 1.383 1.033—1.854 0.029 0.046 * 
 Male 1.542 1.056—2.262 0.025 0.136  
Respiratory (Overall)      
 Female 2.054 1.557—2.719 2.830 x 10-7 1.557 x 10-6 *** 
 Male 0.903 0.583—1.399 0.647 0.792  
Diabetic (Overall)      
 Female 1.692 1.109—2.599 0.015 0.027 * 
 Male 1.509 0.822—2.830 0.186 0.511  
Low Blood Pressure      
 Female 2.541 1.494—4.467 4.821 x 10-4 1.061 x 10-3 ** 
High Blood Pressure      
 Female 0.873 0.578—1.313 0.514 0.628  
 Male 1.158 0.743—1.812 0.517 0.711  
High Cholesterol      
 Female 1.382 0.850—2.248 0.192 0.263  
 Male 1.451 0.867—2.456 0.157 0.511  
Heart Disease      
 Male 1.121 0.501—2.562 0.782 0.860  
Arrhythmia      
 Female 2.928 1.829—4.804 5.002 x 10-6 1.834 x 10-5 *** 
 Male 3.085 1.561—6.458 9.726 x 10-4 0.011 * 
Asthma      
 Female 2.092 1.576—2.789 2.554 x 10-7 1.557 x 10-6 *** 
 Male 0.796 0.499—1.267 0.335 0.612  
Type II Diabetes      
 Female 1.028 0.510—2.055 0.938 0.938  
 Male 1.799 0.688—5.266 0.237 0.522  
Prediabetes      
 Female 4.379 2.102—9.772 5.011 x 10-5 1.378 x 10-4 *** 
 Male 1.020 0.419—2.474 0.964 0.964  
Significance Level:    *** (p < 0.001),          ** (p < 0.01),          * (p < 0.05),           (p < 0.10) 
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Supplementary Table 4: Interaction of Age and Diagnosis in Autistic and Non-



















Cancer (Overall)       
 Female -8.395 x 10-3 0.672 0.878 0.066 4.185 x 10-8 1.151 x 10-7 
 Male -0.028 0.187 0.687 0.063 1.038 x 10-5 3.805 x 10-5 
Cardiovascular (Overall)       
 Female -0.023 0.021 0.228 0.056 1.110 x 10-16 6.106 x 10-16 
 Male -4.459 x 10-4 0.971 0.971 0.057 1.091 x 10-10 1.200 x 10-9 
Respiratory (Overall)       
 Female -1.453 x 10-3 0.878 0.878 -1.511 x 10-3 0.824 0.824 
 Male 4.317 x 10-3 0.749 0.971 3.496 x 10-3 0.730 0.775 
Diabetic (Overall)       
 Female 0.013 0.361 0.878 0.042 1.173 x 10-5 2.580 x 10-5 
 Male 4.356 x 10-3 0.823 0.971 0.029 0.056 0.084 
Low Blood Pressure       
 Female 0.025 0.178 0.654 4.622 x 10-3 0.754 0.824 
High Blood Pressure       
 Female -9.833 x 10-3 0.490 0.878 0.071 0 0 
 Male -0.012 0.417 0.971 0.053 2.012 x 10-7 1.107 x 10-6 
High Cholesterol       
 Female 5.345 x10-3 0.762 0.878 0.070 6.404 x 10-11 2.348 x 10-10 
 Male 0.039 0.033 0.205 0.039 2.477 x 10-3 6.812 x 10-3 
Heart Disease       
 Male 0.068 0.037 0.205 0.050 5.396 x 10-3 0.012 
Arrhythmia       
 Female -2.667 x 10-3 0.867 0.878 0.020 0.123 0.181 
 Male 9.363 x 10-3 0.667 0.971 0.035 0.054 0.084 
Asthma       
 Female 3.451 x 10-3 0.724 0.878 -9.248 x 10-3 0.194 0.237 
 Male 5.660 x 10-4 0.969 0.971 -3.064 x 10-3 0.775 0.775 
Type II Diabetes       
 Female 0.013 0.596 0.878 0.061 1.656 x 10-5 3.035 x 10-5 
 Male 0.039 0.757 0.971 0.027 0.169 0.206 
Prediabetes       
 Female -0.010 0.106 0.582 0.043 0.131 0.181 
 Male -6.969 x 10-3 0.807 0.971 0.037 0.061 0.084 
Significance Level:    *** (p < 0.001),          ** (p < 0.01),          * (p < 0.05),           (p < 0.10) 
 
These are the full results for our analysis on the interaction between age and diagnosis. Although 
there were marginally significant interactions between age and diagnosis for cardiovascular 
conditions overall for autistic females (compared to non-autistic females), as well as for high 
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cholesterol and heart disease for autistic males (compared to non-autistic males), these results 
did not survive correction.  
